Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: a retrospective analysis of the Rete Ematologica Lombarda

MeSH terms

• Aged
• Aged, 80 and over
• Disease-Free Survival
• Female
• Follow-Up Studies
• Humans
• Induction Chemotherapy*
• Leukemia, Myeloid, Acute / diet therapy*
• Leukemia, Myeloid, Acute / mortality*
• Male
• Retrospective Studies
• Survival Rate